[Global Fund] Geneva -- The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has reached a historic milestone by procuring - for the first time - a first-line HIV treatment manufactured in Africa. The treatment - lifesaving, quality-assured antiretroviral medicines (ARVs) called TLD (tenofovir, lamivudine and dolutegravir), prequalified by the World Health Organization - was sourced from a leading Kenyan pharmaceutical company and delivered to Mozambique. The volume supplied can treat over 72,000 people per
